Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005104 |
XU_ID: | XU-651 |
ID: | TCMBANKHE005104/XU-626/XU-651 |
植物拉丁名: |
|
功能与主治: | To stanch bleeding./Precipitate blood of large intestine, hemoptysis, flooding. |
药用植物名: | 刺槐花|刺槐 |
来源: | 贵州省毕节市金沙县 |
药用部位: | flower|枝叶 |
KUMST_ID1: | KMUST-BS-0664 |
KUMST_ID2: | KMUST-2024041200078-1 |
TCM_ID_id: | 1884 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000741 | canaline | AX8039064; BG00900857; 5415AA; ANW-60615; KB-209864; AJ-51600; FCH874697; D-CANALINE; (R)-2-Amino-4-(aminooxy)butanoic acid; 128395-79-9; UNII-T7H2XP1ZNS; TC-149360; CTK4B5934; SCHEMBL440858; DTXSID80436383; ZINC4535965; AK-88063; T7H2XP1ZNS | C4H10N2O3 | 134.13 g/mol | C(CON)C(C(=O)O)N |
| TCMBANKIN004592 | Robinetin | NSC-656274; WLN: T66 BO EVJ CR CQ DQ EQ& DQ IQ; 3,3'',4'',5'',7-pentahydroxy flavone; SR-05000002311-2; 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4-chromenone; EINECS 207-709-6; LS-69031; 4H-1-Benzopyran-4-one, 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl); 3,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-4-benzopyrone; ST24041297; NSC407331; 4H-1-Benzopyran-4-one, 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)- (9CI); KB-234373; 3,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; AK112322; 5-Hydroxyfisetin; AKOS016009494; W1691; UNII-KJ6DBC4U7E; BDBM50033767; MFCD00016783; NCGC00163615-01; NSC-407331; 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromone; SOEDEYVDCDYMMH-UHFFFAOYSA-N; NSC656274; Flavone,3',4',5',7-pentahydroxy-; 5-Deoxymyricetin; LMPK12111577; robinetin; 5-18-05-00562 (Beilstein Handbook Reference); SCHEMBL217743; CCG-208323; FT-0724738; ST50309242; CHEBI:8876; 4CN-0354; AX8150478; NSC 656274; MolPort-004-960-055; 3,7,3',4',5'-pentahydroxyflavone; ZINC4098600; 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one; BRN 0308905; AIDS071290; SR-05000002311; NSC 407331; 3,3',4',5',7-Pentahydroxyflavone; CCRIS 7520; FLAVONE, 3,3',4',5',7-PENTAHYDROXY-; 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 3,7-Dihydroxy-2-(3,4,5-trihydroxy-phenyl)-chromen-4-one; 490-31-3; C10177; AIDS-071290; CHEMBL170405; Norkanugin; AC1NQYWM; ST5309242; MCULE-2330347941; DTXSID30197654; KJ6DBC4U7E; D07NAY; 4H-1-Benzopyran-4-one, 3,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-; 3,7,3',4',5'-Pentahydroxuflavone; AJ-48014; 3,7,3'',4'',5''-Pentahydroxyflavone | C15H10O7 | 302.24 | C1=CC2=C(C=C1O)OC(=C(C2=O)O)C3=CC(=C(C(=C3)O)O)O |
| TCMBANKIN006955 | liquiritigenin-7-o-β-d-(3-o-acetyl)-apio-furanosyl-4'-o-β-d-glucopyranoside | liquiritigenin-7-o-beta-d-(3-o-acetyl)-apiofuranosyl-4'-o-beta-d-glucopyranoside | |||
| TCMBANKIN019824 | canavalia gibberellin i | C19H22O7 | 362.4 g/mol | C=C1CC23CC1(CCC2C45CCCC(C4C3C(=O)O)(C(=O)O5)C(=O)O)O | |
| TCMBANKIN026057 | butrin | C27H32O15 | 596.5 g/mol | C1C(OC2=C(C1=O)C=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)OC5C(C(C(C(O5)CO)O)O)O | |
| TCMBANKIN026554 | 3-Butenyl isothiocyanate | 1-Butene, 4-isothiocyanato-; LS-86393; 4-isothiocyanatobut-1-ene; ZINC02556931; CHEMBL2251722; but-3-enylimino-thioxo-methane; AC1O5S8A; 3386-97-8; Butenylisothiocyanat; (1E)-1-ISOTHIOCYANATOBUT-1-ENE; Butenyl isothiocyanate; 3-butenyl isothiocyanate; EINECS 222-209-8; (E)-1-isothiocyanatobut-1-ene; Butenylisothiocyanate; Butenylisothiocyanat [German]; Isothiocyanic acid, butenyl ester | C5H7NS | 113.18 | CCC=CN=C=S |
| TCMBANKIN028585 | turgorin | C13H15O13S- | 411.32 g/mol | C1=C(C=C(C(=C1O)OC2C(C(C(C(O2)COS(=O)(=O)[O-])O)O)O)O)C(=O)O | |
| TCMBANKIN029006 | piperonal | 1,3-benzodioxole-5-carbaldehyde; FR-0263; 3,4-Dihydroxybenzaldehyde methylene ketal; Heliotropine; CCRIS 5928; 3,4-(Methylenedioxy)benzaldehyde; NCGC00091137-01; CHEBI:8240; Geliotropin; 120-57-0; W291102_ALDRICH; 3,4-Methylene-dihydroxybenzaldehyde; C10812; 3,4-Methylenedioxybenzaldehyde; WLN: T56 BO DO CHJ GVH; Heliotropin (natural); NSC 26826; SBB007752; Piperonylaldehyde; 5-Formyl-1,3-benzodioxole; Dioxymethylene protocatechuic aldehyde; Piperonyl aldehyde; Benzaldehyde, 3,4-(methylenedioxy)-; InChI=1/C8H6O3/c9-4-6-1-2-7-8(3-6)11-5-10-7/h1-4H,5H; Piperonaldehyde; Protocatechuic aldehyde methylene ether; EINECS 204-409-7; ZINC00001953; NSC26826; FEMA No. 2911; 3,4-Dimethylenedioxybenzaldehyde; 1,3-Benzodioxole-5-carboxaldehyde; 80820_FLUKA; P49104_ALDRICH; 3,4-METHYLEN-DIOXY-BENZALDEHYDE; 3,4-Bis(methylenedioxy)benzaldehyde; AI3-01198; Dioxymethylene-protocatechuic aldehyde; 30024-74-9; HSDB 581; Piperonal; LS-631; Heliotropin | C8H6O3 | 150.13 g/mol | C1OC2=C(O1)C=C(C=C2)C=O |
| TCMBANKIN030346 | 3,4,5,2',4'-pentahydroxychalcone | C15H12O6 | 288.25 g/mol | C1=CC(=C(C=C1O)O)C(=O)C=CC2=CC(=C(C(=C2)O)O)O | |
| TCMBANKIN031943 | methylrosmarinate | methyl rosmarinate | C19H18O8 | 374.34 | COC(=O)C(CC1=CC(=C(C=C1)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O |
| TCMBANKIN036804 | acacetin | Linarigenin; KBio2_000595; AIDS014771; SPECTRUM200499; 480-44-4; Acaceztin; 4'-Methoxy-5,7-dihydroxyflavone; Akatsetin; A827453; KBio1_000878; 5,7-Dioxy-4'-methoxyflavone; Apigenin 4'-dimethyl ether; NSC76061; CHEBI:15335; Prestwick1_000695; Spectrum_000135; 5,7-dihydroxy-2-(4-methoxyphenyl)-4-chromenone; NINDS_000878; 00017_FLUKA; ZINC00005600; Acacetin; AIDS-014771; WLN: T66 BO EVJ CR DO1& GQ IQ; Acacetine; IDI1_000878; Flavone, 5,7-dihydroxy-4'-methoxy- (8CI); 5,7-Dihydroxy-2-(4-methoxyphenyl)-4-benzopyrone; Prestwick0_000695; NSC 76061; Spectrum5_000930; SPBio_002770; CHEBI:57284; KBioSS_000595; Prestwick_49; NCGC00095213-03; BCBcMAP01_000082; NCGC00016458-01; KBio2_003163; BPBio1_000935; Prestwick2_000695; KBio2_005731; ACAETIN; SMP1_000001; Apigenin 4'-methyl ether; DivK1c_000878; 7-hydroxy-2-(4-methoxyphenyl)-4-oxo-1-benzopyran-5-olate; Prestwick3_000695; 5,7-dihydroxy-2-(4-methoxyphenyl)chromone; 5,7-Dihydroxy-4'-methoxyflavone; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(4-methoxyphenyl)-; 5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one; BRN 0277879; Flavone, 5,7-dihydroxy-4'-methoxy-; 2-(4-methoxyphenyl)-7-oxidanyl-4-oxidanylidene-chromen-5-olate; C01470; CAS-480-44-4; Buddleoflavonol; NCGC00095213-01; Linarisenin; EINECS 207-552-3; 5-18-04-00575 (Beilstein Handbook Reference); NCGC00095213-02; ST066889; BSPBio_000849; Apisenin 4'-methyl ether; acacetin ; 5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-olate; 4'-Methoxyapigenin; 5,7-dihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one | C16H12O5 | 284.263 | c1([H])c(OC(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])=C([H])C3=O)c3c(O[H])c([H])c1O[H] |
| TCMBANKIN036810 | Butein | 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 2′,4′,3,4-Tetrahydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-; NCGC00163519-01; (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; NSC652892; AIDS057944; AC1NST6X; AIDS-057944; 3,4,2',4'-Tetrahydroxychalcone; ST5331397; 2',3,4,4'-Tetrahydrochalcone; 2',3,4,4'-Tetrahydroxychalcone; B178_SIGMA; butein ; MolMap_000005; Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI); EINECS 207-659-5; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-; C08578; butein; 2',4',3,4-Tetrahydroxychalcone; 2′,3,4,4′-Tetrahydroxychalcone; Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihydroxyphenyl)-; NCI60_018489; HSCI1_000162; 21849-70-7; (Z)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 487-52-5; 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one | C15H12O5 | 272.25 | C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O)O |
| TCMBANKIN038308 | isoliquiritin | MolPort-001-742-630; 7014-39-3; 5041-81-6; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-(beta-D-glucopyranosyloxy)phenyl)-, (2E)-; C16978; Q-100563; BDBM50362885; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]prop-2-en-1-one; SCHEMBL676338; 4-beta-D-glucopyranosyloxy-2',4'-dihydroxy-trans-chalcone; I07-0258; Isoliquiritin; X1193; 2Y348H1V4W; MEGxp0_001945; YNWXJFQOCHMPCK-LXGDFETPSA-N; CHEMBL599763; UNII-2Y348H1V4W; AKOS015897131; X1167; AC1NSX26; BG01706425; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-[4-(.beta.-D-glucopyranosyloxy)phenyl]-, (2E)-; AK554321; AT-28971; 4-[(1E)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenyl beta-D-glucopyranoside; N1750; (E)-1-(2,4-dihydroxyphenyl)-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-en-1-one; MFCD00272145; ZINC33832004; LMPK12120021; 4-(beta-D-Glucopyranosyloxy)-2',4'-dihydroxychalcone; AK544982; CHEBI:80839; Neoisoliquritin | C21H22O9 | 418.394 | c1([H])c(O[H])c(C(=O)\C([H])=C([H])\c2c([H])c([H])c(O[C@]3([H])O[C@]([H])(C([H])([H])O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])c([H])c2[H])c([H])c([H])c1O[H] |
| TCMBANKIN041703 | dihydrorobinetin | C15H12O7 | 304.25 g/mol | C1=CC2=C(C=C1O)OC(C(C2=O)O)C3=CC(=C(C(=C3)O)O)O | |
| TCMBANKIN042651 | apigenin bioside | apigenin-bioside | C26H28O13 | CC1C(C(C(C(O1)OC2=CC(=C3C(=C2)OC(=CC3=O)C4=CC=C(C=C4)O)O)O)O)OC5C(C(C(CO5)O)O)O | |
| TCMBANKIN046672 | Retamine | 250.38 g/mol | |||
| TCMBANKIN046884 | (E)-2-Hexenyl-gamma-L-arabinopyranosyl-(1-2)-beta-D-glucopyranoside | (e)-2-hexenyl-gamma-l-arabinopyranosyl-(1-2)-beta-d-glucopyranoside | C17H30O10 | 380.388 | C(/C([H])([H])O[C@@]1([H])[C@]([H])(O[C@@]2([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O2)[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])O1)([H])=C([H])\C([H])([H])C([H]) ([H])C([H])([H])[H] |
| TCMBANKIN047189 | Turmerone | CHEBI:81132; ZINC13377636; (S)-Turmerone; C17494; CHEMBL2272665 | C15H26O | 222.366 | C([H])([H])([H])C1([H])C([H])([H])C([H])([H])C([H])([C@]([H])(C([H])([H])C(\C([H])=C(/C([H])([H])[H])\C([H])([H])[H])=O)C([H])([H])[H])C([H])([H])C1([H])[H] |
| TCMBANKIN058104 | 2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxy-chromone | 2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxy-4-chromenone; 2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(2,6-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; 3,5,7,2',6'-Pentahydroxy flavonol; 92519-95-4;3,5,7,2',6'-pentahydroxy flavone | C15H10O7 | 302.24 g/mol | C1=CC(=C(C(=C1)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN058113 | Butein | 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 2′,4′,3,4-Tetrahydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-, (2E)-; NCGC00163519-01; (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; NSC652892; AIDS057944; AC1NST6X; AIDS-057944; 3,4,2',4'-Tetrahydroxychalcone; ST5331397; 2',3,4,4'-Tetrahydrochalcone; 2',3,4,4'-Tetrahydroxychalcone; B178_SIGMA; butein ; MolMap_000005; Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI); EINECS 207-659-5; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-; C08578; butein; 2',4',3,4-Tetrahydroxychalcone; 2′,3,4,4′-Tetrahydroxychalcone; Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihydroxyphenyl)-; NCI60_018489; HSCI1_000162; 21849-70-7; (Z)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one; 487-52-5; 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one | C15H12O5 | 272.25 | C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O)O |
| TCMBANKIN058173 | DOB | beta-Resorcylic acid; RESORCYLIC ACID, BETA; Benzoic acid, 2,4-dihydroxy-; STK299216; NSC4740; NSC 13564; 4-Carboxyresorcinol; D109401_ALDRICH; 4-Hydroxysalicylic acid; .beta.-Resorcinolic acid; 2,4-Dihydroxybenzoic acid; NSC13564; AIDS-018062; W379808_ALDRICH; 4-10-00-01420 (Beilstein Handbook Reference); InChI=1/C7H6O4/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,8-9H,(H,10,11; .beta.-Resorcylic acid; 89-86-1; BRA; AI3-24366; beta-Resorcinolic acid; 37530_FLUKA; 2,4-Dhba; EINECS 201-946-9; BRN 1946213; AIDS018062; Oprea1_259729; NCGC00090922-02; p-Hydroxysalicylic acid; NCGC00090922-01;β-resorcylicacid | C7H6O4 | 154.12 g/mol | C1=CC(=C(C=C1O)O)C(=O)O |
| TCMBANKIN058192 | isoliquiritigenin | HCC; KBio2_000625; SPBio_000949; Spectrum2_000875; 961-29-5; 2-PROPEN-1-ONE, 1-(2,4-DIHYDROXYPHENYL)-3-(4-HYDROXYPHENYL)-; SPECTRUM1504200; Chalcone, 2',4,4'-trihydroxy-; CHEMBL1395334; KBio3_002631; NCGC00015556-01; SDCCGMLS-0066751.P001; ST5309279; (2E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; KBio2_003193; InChI=1/C15H12O4/c16-11-4-1-10(2-5-11)3-8-14(18)13-7-6-12(17)9-15(13)19/h1-9,16-17,19H/b8-3; (E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; CMLD3_000056; BSPBio_003411; C08650; CCRIS 7676; 2',4,4'-Trihydroxychalcone; Lopac0_000681; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; I159_SIGMA; 1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; Lopac-I-3766; CPD-3041; KBio1_001802; MEGxp0_001326; ZINC3869607; BRN 1914295; MLS000438943; SMR000112969; Acrylophenone, 2',4'-dihydroxy-3-(p-hydroxyphenyl)-; (2E)-1-(2,4-Dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one; ACon1_000047; GU 17; KBioGR_002232; DivK1c_006858; KBio2_005761; 1-08-00-00707 (Beilstein Handbook Reference); 4,2′,4′-Trihydroxychalcone; (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; NCGC00090504-01; (Z)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one; EU-0100681; Spectrum3_001656; AC1O7G44; 4,2',4'-Trihydroxychalcone; EINECS 237-316-5; I3766_SIGMA; AIDS035379; AIDS-035379; 13745-20-5; Spectrum5_000612; 2-propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (2E)-; Spectrum_000145; KBioSS_000625; Isoliquiritigenin; Spectrum4_001756; 42'4'-trihydroxychalcone; 2-Propen-1-one, 1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-, (E)-; NCGC00090504-03; SpecPlus_000762; 2',4',4-trihydroxychalcone | C15H12O4 | 256.25 g/mol | C1=CC(=CC=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O |
| TCMBANKIN058502 | robinetinidol-(4α→8)-catechin-(6→4α)-robinetinidol | robinetinidol-(4alpha-8)-catechin-(6-4alpha)-robinetinidol | C45H38O18 | C1C(C(OC2=C1C(=C(C(=C2C3C(C(OC4=C3C=CC(=C4)O)C5=CC(=C(C(=C5)O)O)O)O)O)C6C(C(OC7=C6C=CC(=C7)O)C8=CC(=C(C(=C8)O)O)O)O)O)C9=CC(=C(C=C9)O)O)O | |
| TCMBANKIN058535 | butin | ACon1_000269; MolPort-001-740-173; 4CN-1039; MCULE-9899038190; BRD-A75085792-001-01-8; MEGxp0_000004; AC1MRPVU; 21913-99-5; SCHEMBL5504140; 3',4',7-Trihydroxyflavanone; NCGC00180724-01; NP-000008; 2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrochromen-4-one; CHEMBL3401430 | C27H30O16 | 610.52 | C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC(=C(C=C3)O)O |
| TCMBANKIN058536 | (2S)-liquiritigenin;liquiritigenin;DFV | (2R)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; N1793; AJ-23291; AC1LICLD; ZINC519174;4',7-Dihydroxyflavanone; 5-DEOXYFLAVANONE; 578-86-9; 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-, (S)-; 7-HYDROXY-2-(4-HYDROXY-PHENYL)-CHROMAN-4-ONE; (2S)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2S)-7-Hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one; ZINC00985403; 2885-30-5; 17002-53-8; C09762; Liquiritigenin; 7,4'-Dihydroxyflavanone; (2S)-7-hydroxy-2-(4-hydroxyphenyl)-4-chromanone; STOCK1N-11167; 16006-91-0 | C15H12O4 | 256.25 g/mol | C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O |
| TCMBANKIN059233 | dimidin | C21H24O7 | 388.4 g/mol | CC(C)CC(=O)OC1C(C2=C(C=CC3=C2OC(=O)C=C3)OC1(C)C)OC(=O)C | |
| TCMBANKIN060271 | acacetin-7-O-rutinoside | C28H32O14 | 592.5 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC=C(C=C5)OC)O)O)O)O)O)O)O | |
| TCMBANKIN060716 | β-hexenol | C6H12O | 100.16 g/mol | CCC=CCCO | |
| TCMBANKIN061400 | methyl 2,4-dihydroxybenzoate | methyl-β-resorcylate; methyl-beta-resorcylate | C8H8O4 | 168.15 g/mol | COC(=O)C1=C(C=C(C=C1)O)O |
| TCMBANKIN061771 | piplartine | Prestwick_399; 1-[3-(3,4,5-Trimethoxy-phenyl)-acryloyl]-5,6-dihydro-1H-pyridin-2-one; 5,6-Dihydro-1-(3,4,5-trimethoxycinnamoyl)-2(1H)-pyridone; MolPort-001-741-398; CHEMBL465843; HMS2096J10; J-012992; BPBio1_000560; NCGC00096028-01; CHEBI:8241; BRD-K24132293-001-05-3; BRD-K24132293-001-09-5; AM-730/20761034; ZB015157; (E)-1-[3-(3,4,5-Trimethoxyphenyl)acryloyl]-5,6-dihydropyridin-2(1H)-one; AC1LCV4N; 2659AH; (E)-1-(3-(3,4,5-trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one; PPLGM; SCHEMBL2465593; (2E)-1-(1,2,5,6-Tetrahydro-2-oxopyridine-1-yl)-3-(3,4,5-trimethoxyphenyl)-2-propene-1-one; CCG-214375; Prestwick2_000604; Piperlongumine; BRD2293; 5,6-Dihydro-1-(1-oxo-3-[3,4,5-trimethoxyphenyl]-trans-2-propenyl)-2[1H]-pyridinone; SGD66V4SVJ; ZINC899053; NCGC00096028-03; 5,6-Dihydro-1-(3,4,5-trimethoxycinnamoyl)-2(1H)-pyridinone; MFCD00075706; 20069-09-4; C10166; SCHEMBL173092; BRD-K24132293-001-16-0; (E)-5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone; Prop-2-en-1-one, 3-(3,4,5-trimethoxyphenyl)-1-(2,3-dihydropyridin-6(1H)-one-1-yl)-; Piplartin; 2(1H)-Pyridinone,5,6-dihydro-1-[(2E)-1-oxo- 3-(3,4,5-trimethoxyphenyl)-2-propenyl]-; A1-00162; HMS1569J10; VABYUUZNAVQNPG-BQYQJAHWSA-N; 5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl]-2(1H)-pyridinone, 9CI; 2(1H)-Pyridinone, 5,6-dihydro-1-(1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propenyl)-, (E)-; SR-01000841248; ACon1_001541; UNII-SGD66V4SVJ; Prestwick3_000604; BSPBio_000508; HMS2234K24; 1-[(2E)-3-(3,4,5-Trimethoxyphenyl)-2-propenoyl]-5,6-dihydro-2(1H)-pyridinone #; BRD-2293; 5,6-Dihydro-1-[1-oxo-3-(3,4,5-trimethoxyphenyl)-trans-2-propenyl]-2(1H)-pyridinone; NCGC00096028-04; SMR001233252; MLS002153903; N-(3,4,5-Trimethoxycinnamoyl)-D3-piperidin-2-one; P2361; 1-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-1,5,6-trihydropyridin-2-one; Piperlongumin; ST079382; CHEBI:92424; 1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one; AKOS024284776; NCGC00096028-02; Piperlongumine, >=97% (HPLC); C-54604; s7551; 1-[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-1,2,5,6-tetrahydropyridin-2-one; AK326371; 5,6-Dihydro-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-pyridinone; SR-01000841248-2; Piplartine; 4CN-2875; SPECTRUM1505135; piperlongumine | C17H19NO5 | 317.34 g/mol | COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab